Person: REZVANİ, AYLİN
8 results
Search Results
Now showing 1 - 8 of 8
Publication Metadata only Correlations among enthesitis, clinical, radiographic and quality of life parameters in patients with ankylosing spondylitis.(2014-07-01) Rezvani, AYLİN; BODUR, H; ATAMAN, S; KAYA, T; BUĞDAYCı, DS; DEMIR, SE; KOÇYIĞIT, H; ALTAN, L; UĞURLU, H; KıRNAP, M; GÜR, A; KOZANOĞLU, E; AKıNCı, A; TEKEOĞLU, I; SAHIN, G; BAL, A; SIVRIOĞLU, K; YAZGAN, P; AYDıN, G; HEPGÜLER, S; OLMEZ, N; ŞENDUR, ÖF; YENER, M; ALTAY, Z; AYHAN, F; DURMUŞ, O; DURUÖZ, MT; GÜNENDI, Z; NACıR, B; OKEN, O; TOKTAŞ, H; DELIALIOĞLU, SÜ; EVCIK, D; SERTPOYRAZ, FM; REZVANİ, AYLİNPublication Metadata only Factor XI deficiency diagnosed following use of adalimumab.(2014-09-01) KARATOPRAK, CUMALİ; CETIN, GÜVEN; KISKAC, MUHARREM; ZORLU, MEHMET; Rezvani, AYLİN; CIKRIKCIOGLU, MA; ÇETİN, GÜVEN; KARATOPRAK, CUMALİ; KISKAÇ, MUHARREM; ZORLU, MEHMET; REZVANİ, AYLİNPublication Open Access Differential diagnosis of multiple vertebral compression: butterfly vertebrae.(2015-11-01) OZARAS, N; GUMUSSU, K; DEMIR, SE; Rezvani, AYLİN; REZVANİ, AYLİN[Purpose] A butterfly vertebra is a rare congenital anomaly resulting from a symmetric fusion defect. Only a few cases of butterfly vertebra have been described. This anomaly may be isolated or associated with Pfeiffer, Jarcho-Levins, Crouzon, or Alagille syndrome. [Subject and Methods] We herein describe a 38-year-old man who presented with neck and low back pain and was found to have butterfly vertebrae at the T9 and L3 levels. He also had Behçet’s disease and psoriasis. [Results] The patient’s symptoms improved with analgesics and physiotherapy. [Conclusion] To our knowledge, butterfly vertebrae at two levels have never been reported. Butterfly vertebrae may be confused with vertebral fractures in lateral radiographs, and awareness of this anomaly is important for a correct diagnosisPublication Open Access Influence of patient training on persistence, compliance, and tolerability of different dosing frequency regimens of bisphosphonate therapy: An observational study in Turkish patients with postmenopausal osteoporosis.(2016-08-01) AKARıRMAK, Ü; KOÇYIĞIT, H; ESKIYURT, N; ESMAEILZADEH, S; KURU, Ö; YALÇINKAYA, EY; PEKER, Ö; EKIM, AA; ÖZGIRGIN, N; ÇALıŞ, M; Rezvani, AYLİN; ÇEVIKOL, A; EYIGÖR, S; ŞENDUR, ÖF; İRDESEL, J; INSTRUCT, Study; REZVANİ, AYLİNObjective: In our study, we aimed to evaluate the influence of training on compliance and persistence with bisphosphonate treatment given on a weekly vs. monthly basis in postmenopausal osteoporosis patients. Methods: A total of 979 patients with postmenopausal osteoporosis (mean age: 63.2 ± 7.2 years) were included in this national, multicenter, prospective non-interventional observational cohort registry study. Patients were randomized into training (n ¼ 492, 50.3%, mean age: 63.4 ± 7.2 years) and control (n ¼ 487, 49.7%, mean age: 63.0 ± 7.1 years) groups. Patients in each intervention group were given weekly (44.9% and 44.6% for training and control subjects, respectively) or monthly (55.1% and 55.4%, respectively) bisphosphonate regimens. After the initial visit, patients were followed up at three-month intervals throughout 12 months of treatment for evaluation of persistence, compliance and adverse events. Results: On average, 79.4% of the patients were persistent with the treatment with a mean of 350.4 days of duration during the 12-month follow-up period. The mean compliance in the compliant and fully compliant group remained at an average of 86.6%. No significant difference was detected between the training and control groups in terms of compliance and persistence. Significantly longer persistence (360.0 ± 89.0 vs. 345.0 ± 108.0 days; p ¼ 0.035), higher percentage of persistent patients (83.4% vs. 74.2%; p ¼ 0.012) and higher compliance rates (88.8% vs. 83.3%; p ¼ 0.002) were noted in monthly regimen patients in comparison to those given weekly regimen. Conclusion: Our findings revealed remarkably high rates for persistence and compliance with bisphosphonate treatment in postmenopausal osteoporosis, with no impact of training on compliance and persistence rates. Longer persistence and better compliance rates were achieved with the monthly bisphosphonate regimen when compared to the weekly regimen.Publication Open Access The relationship between body mass index, waist circumference and psoriatic arthritis in the Turkish population(2016-01-01) OZKAYA, Dilek Biyik; Onsun, NAHİDE; Su, Ozlem; Bahali, ANIL GÜLSEL; Dizman, DİDEM; Rezvani, AYLİN; Uysal, Omer; ONSUN, NAHIDE; SU KÜÇÜK, ÖZLEM; BAHALI, ANIL GÜLSEL; DİZMAN, DİDEM; REZVANİ, AYLİN; UYSAL, ÖMERIntroduction: Psoriasis is a chronic, immune-mediated inflammatory disease predominantly affecting the skin, with a complex aetiology. Recently it has been suggested that the chronic inflammation of psoriasis may cause metabolic and vascular disorders. The relationship between obesity and psoriatic arthritis (PsA) is not clear, and there are insufficient prospective studies addressing this subject. Aim: To investigate the relationship between psoriatic arthritis, severity of psoriasis and obesity in the Turkish population. Material and methods: Patient data from psoriasis outpatient clinics from February 2007 to July 2013 were reviewed retrospectively using the Psoriasis-Turkey (PSR-TR) registration system. Patients' age, onset age, body mass index (BMI), waist circumference, psoriasis area and severity index (PASI), and arthritis information were reviewed. In the outpatient clinics, patients who had joint pain consulted rheumatology clinics. The CASPAR criteria were used for the diagnosis of arthritis. Results: A total of 443 males and 495 females enrolled in this study. The mean age of females was 43.9 years (18-93 years) and the mean age of males was 44.6 years (18-89 years). A total of 231 (25%) patients had psoriatic arthritis. Investigation of the relationship between PASI, BMI, waist circumference (WC) and arthritis revealed a statistically significant relationship between each variable. Conclusions: In this study we observed a relationship between PsA and high BMI, high WC and high PASI. Psoriatic arthritis is a chronic inflammatory disorder and a chronic inflammatory state induced by adiposity may lead to PsA.Publication Metadata only Coexistence of Ankylosing Spondylitis With Morphea: A Case Report(2014-06-01) GUMUSSU, Kevser; Rezvani, AYLİN; Su, Ozlem; OZARAS, Nihal; GULER, Mustafa; REZVANİ, AYLİN; SU KÜÇÜK, ÖZLEMMorphea, which is also known as localized scleroderma, is a disorder caused by excessive collagen deposition and characterized by the thickening and hardening of the skin. Unlike systemic sclerosis, morphea lacks features such as Raynaud phenomenon, joint involvement, sclerodactyly, and constitutional symptoms. It may be associated with drug use and is occasionally found together with other autoimmune diseases. In this article, we report a 60-year-old woman who was admitted to our outpatient clinic due to HLA B27 + ankylosing spondylitis with axial involvement and morphea. Her disease was able to be managed with exercise and non-steroidal anti-inflammatory drugs, however, a 10x7 cm diameter atrophic lesion of medium hardness was identified on her left shoulder. The histopathology of the lesion was compatible with morphea, and improved with topical steroid treatment. Although the concomitance of autoimmune diseases is frequent, there is no coexistence of morphea with ankylosing spondylitis in the literature, except a case who was considered to be associated with the adalimumab use. Despite limited data, however, common autoimmune pathogenesis may be seen in association with ankylosing spondylitis and morphea.Publication Open Access Reliability and validity of the Turkish version of the fibromyalgia rapid screening tool (FiRST).(2017-02-01) CELIKER, R; ALTAN, L; Rezvani, AYLİN; AKTAS, I; TASTEKIN, N; DURSUN, E; DURSUN, N; SARıKAYA, SİYAMİ; OZDOLAP, S; AKGUN, K; ZATERI, C; BIRTANE, M; REZVANİ, AYLİN; SARIKAYA, SİYAMİ[Purpose] An easy-to-use, psychometrically validated screening tool for fibromyalgia is needed. This study aims to evaluate the reliability and validity of the Turkish version of the Fibromyalgia Rapid Screening Tool by correlating it with 2013 American College of Rheumatology alternative diagnostic criteria and the Hospital Anxiety and Depression Scale. [Subjects and Methods] Subjects were 269 Physical Medicine and Rehabilitation clinic outpatients. Patients completed a questionnaire including the Fibromyalgia Rapid Screening Tool (twice), 2013 American College of Rheumatology alternative diagnostic criteria, and the Hospital Anxiety and Depression Scale. Scale reliability was examined by test-retest. The 2013 American College of Rheumatology alternative diagnostic criteria was used for comparison to determine criterion validity. The sensitivity, specificity, and positive and negative likelihood ratios were calculated according to 2013 American College of Rheumatology alternative diagnostic criteria. Logistic regression analysis was conducted to find the confounding effect of the Hospital Anxiety and Depression Scale on Fibromyalgia Rapid Screening Tool to distinguish patients with fibromyalgia syndrome. [Results] The Fibromyalgia Rapid Screening Tool was similar to the 2013 American College of Rheumatology alternative diagnostic criteria in defining patients with fibromyalgia syndrome. Fibromyalgia Rapid Screening Tool score was correlated with 2013 American College of Rheumatology alternative diagnostic criteria subscores. Each point increase in Fibromyalgia Rapid Screening Tool global score meant 10 times greater odds of experiencing fibromyalgia syndrome. [Conclusion] The Turkish version of the Fibromyalgia Rapid Screening Tool is reliable for identifying patients with fibromyalgia.Publication Metadata only Relationship of CTLA4 and CD28 polymorphisms with lung involvement, HRCT findings and pulmonary function tests in Turkish patients with ankylosing spondylitis(2017-09-01) Okyaltirik, FATMANUR; Rezvani, AYLİN; Turan, Saime; Uysal, Omer; YAKAR, Fatih; SÖZGEN, Hatice; Ozkan, Nazli Ezgi; Akkoyunlu, Muhammet Emin; Bayram, MEHMET; Ozcelik, Hatice Kutbay; Sezer, Murat; GÜLER, Mustafa; Yaylim, Ilhan; Kart, Levent; OKYALTIRIK, FATMANUR; REZVANİ, AYLİN; UYSAL, ÖMER; BAYRAM, MEHMETBackground and AimsAnkylosing spondylitis (AS) is a multisystem disorder with ocular, pulmonary, and cardiovascular involvement. The incidence of pulmonary involvement varies from 1 to 52%. Abnormal T-cell function-derived immune responses are involved in AS pathogenesis. Numerous genes such as CTLA4 and CD28 control T-cell functions. In this study, we aimed to address the relationship between CTLA4 and CD28 polymorphisms and lung involvement in Turkish patients with AS.